Abstract. MicroRNA (miR)-29a has been associated with carcinogenesis in humans; however, its functional significance in esophageal squamous cell carcinoma (ESCC) is yet to be determined. In the present study, the expression of miR-29a was markedly downregulated in ESCC tissue and the ESCC TE-1 cell line, compared with normal esophageal tissue and cells. Furthermore, the present study identified that the forced expression of miR-29a in TE-1 cells significantly reduced cell proliferation and migration. miR-29a overexpression did not affect the expression of Notch1, however, it did increase the gene expression levels of hairy and enhancer of split 1 (Hes1), which is the key effector of the Notch signaling pathway. Direct targeting by miR-29a resulted in the downregulation of nuclear factor 1 A (Nfia), which represses the transcriptional activity of the Hes1 promoter. Furthermore, knockdown of Nfia increased Hes1 expression and inhibited cell growth in TE-1 cells. These results indicate that a low level of miR-29a expression is involved in ESCC tumorigenesis, and exogenous expression of miR-29a may repress cancer cell growth by downregulating Nfia and activating the Notch signaling pathway.
Introduction
MicroRNAs (miRNAs) are a conserved class of endogenous non-coding small RNAs (length, 20-22 nt) that regulate gene expression at the post-transcriptional level. This predominantly occurs by binding to the 3'-untranslated region (UTR) mRNA of target genes, resulting in mRNA degradation and, thus, inhibition of translation (1) (2) (3) . Recent studies have indicated that miRNA expression may be important in in the progression and outcome of various diseases (4, 5) . Although studies investigating miRNA expression profiles in esophageal carcinoma have been conducted (6) , there remains little information available regarding specific miRNA expression patterns and their roles in esophageal squamous cell carcinoma (ESCC).
The Notch signaling pathway is important in stem cell maintenance and angiogenesis, as well as decisions regarding cell fate in cancer (7) . Notch signaling is important for esophageal epithelial homeostasis, for example Notch signaling regulates cell proliferation within the squamous epithelia (8, 9) . Following activation of the Notch receptor, the Notch intracellular domain (NICD) is cleaved, released and translocated to the nucleus, where, in association with recombination signal binding protein for immunoglobulin ΚJ, it induces the expression of downstream target genes, including the hairy and enhancer of split (HES)/hairy and enhancer of split related with YRPW motif family of transcription factors (10) .
The present study investigated the expression of miR-29a in ESCC and the role of miR-29a in cell growth and migration of the ESCC TE-1 cell line. Furthermore, the mechanisms of miR-29a modulation during TE-1 cell growth were evaluated.
Materials and methods
Cell lines. Primary cultures of normal esophageal epithelial cells (NEECs) were established from fresh biopsies of noncancerous esophageal tissues, in accordance with a previous study (11) . The NEECs and ESCC cells were cultured in keratinocyte serum-free medium (Gibco Life Technologies, Carlsbad, CA, USA) supplemented with 40 µg/ml bovine pituitary extract (Gibco Life Technologies), 1.0 ng/ml epidermal growth factor (Invitrogen Life Technologies, Inc., Carlsbad, CA, USA) 100 U/ml penicillin (Gibco Life Technologies) and 100 µg/ml streptomycin (Gibco Life Technologies), at 37˚C and an atmosphere of 5% CO 2 ). The nuclear factor 1 A (Nfia) mRNAs were determined using SYBR ® -Green real-time PCR assay. The PCR primers were as follows: Sense, 5'-ACCAGCTCAAAAAACCTGTGGA-3' and anti-sense, 5'-TGTTGTGAAACGAAACACCCC-3' for Nfia; sense, 5'-CACTGTGGGCGGGTCC-3' and anti-sense, 5'-GTTGTATTGGTTCGGCACCAT-3' for Notch1; sense, 5'-GTGTTAACGCCCTCACACG-3' and anti-sense, 5'-TGGGAGGCAGACTAGCAGAG-3' for Hes1; and sense, 5'-TTCAGCTCTGGGATGACCTT-3' and anti-sense, 5'-TGCCACTCAGAAGACTGTGG-3' for GAPDH. GAPDH was used to normalize the mRNA expression.
Lentiviral-mediated miR-29a overexpression and Nfia knockdown in mesenchymal stem cells. The miR-29a precursor vector and scramble plasmid were obtained from GeneCopoeia Inc., (cat no. RmiR6139; Guangzhou, China) and contained the puromycin selection marker. The lentivirus containing miR-29a precursor was generated using the Lenti-Pac™ Human Immunodeficiency Virus Expression Packaging kit (GeneCopoeia Inc.). Briefly, the DNA-EndoFectin complex was formed by adding 2.5 µl lentiviral miR-29a precursor expression plasmid/scramble plasmid to 5.0 µl EndoFectin™ Lenti transfection reagent diluted into Opti-MEM ® . Following a 20-min incubation at room temperature, the DNA-EndoFectin complex was added to a petri dish containing 293T cells that had been plated in Dulbecco's modified Eagle's medium (DMEM; Gibco Life Technologies) supplemented with 10% FBS and incubated in 5% CO 2 at 37˚C overnight. The culture medium was replaced with fresh DMEM supplemented with 5% FBS and TiterBoost™ reagent (1:500; GeneCopoeia, Rockville, MD, USA), and incubation was continued. The virus pseudovirus-containing culture medium was collected 48 h post-transfection, filtered and concentrated. For lentiviral transduction, TE-1 cells were incubated for 2 h at 4˚C, and 1x10
6 TE-1 cells were plated with 20 µl virus suspension and cultured in an atmosphere of 5% CO 2 at 37˚C for 48 h. Following incubation, 10 µg/ml puromycin (EMD Millipore, Billerica, MA, USA) was added to the cells, all of which were subsequently preserved in a medium containing puromycin (final concentration, 10 µg/ml). The TE-1 cells stably expressing the exogenous genes, miR-29a precursor or scramble, were termed miR-29a-TE-1 cells or scramble-TE-1 cells, respectively. The siRNA vector against Nfia and the scramble plasmid were obtained from GeneCopoeia, Inc.
MTT assay. Cells were seeded onto 96-well plates at a density of 5x10 4 cells/well in 100 µl medium. All cells were maintained in a humidified incubator at 37˚C and an atmosphere of 5% CO 2 . MTT (20 µl; 5g/l) was added to each well of the microplate and a microplate reader (Anthros 2010; Biochrom Ltd., Cambridge, UK) was used to measure the absorbance at 570 nm. Following a 4-h incubation, the number of viable cells was measured. Five wells were counted at each time point and the mean was calculated.
Flow cytometry. The percentage of sub-G1 population (apoptotic) cells and the cell cycle distribution were determined using flow cytometry, based on the relative DNA content as previously described (12) . The data were analyzed using ModFit LT software (version 3.1; Verity Software House, Topsham, ME, USA).
Colony formation assays. Cells were plated on 60-mm plates (0.5x10 3 cells/plate) and cultured for 10 days. The colonies were stained with 1% crystal violet for 30 sec following fixation with 10% formaldehyde for 5 min.
In vitro scratch assay. TE-1 cells (5x10 6 cells/well) were seeded in a six-well plate and cultured overnight to reach a confluence of 90%. The following day, a scratch was made through the center of each well using a 200-µl pipette tip, creating an obvious open scratch or wound on the cells. The dislodged cells were removed by washing three times with the complete culture media, and the remaining cells were incubated under standard conditions. Migration into the open area was identified 72 h post-scratching. In addition, TE-1 cells were transfected with lentivirus containing a miR-29a precursor or control for four days then treated with 20 ng/ml epidermal growth factor (EGF; Sigma-Aldrich, St. Louis, MO, USA) for 16 hrs and seeded in six-well plates. After the cells had reached 90% confluence, a scratch was made in the monolayer.
Western blot analysis. TE-1 cells were washed with phosphate-buffered saline (PBS; Gibco Life Technologies), then 200 µl/well cell lysis buffer (Beyotime Institute of Biotechnology, Haimen, China) and 1 mM phenylmethanesulfonyl fluoride were added. Next, the cell lysate was Statistical analysis. Statistical evaluation of the data was conducted using SPSS analysis software (version 13; SPSS Inc., Chicago, IL, USA) and comparisons were performed using the Wilcoxon signed-rank test or independent samples t-tests. P<0.05 was considered to indicate a statistically significant difference.
Results

miR-29a expression is downregulated in ESCC tissues and the ESCC TE-1 cell line.
RT-qPCR analysis revealed that the expression of miR-29a was significantly lower in the ESCC TE-1 cell line compared with in NEECs (Fig. 1A) .
To understand whether this miR-29a downregulation was clinically correlated with ESCC progression, a comparative analysis of miR-29a expression was conducted on paired primary cancerous tissue and adjacent non-cancerous tissue from nine cases of ESCC. RT-qPCR analysis revealed that the expression of miR-29a was significantly lower in the tumor tissue compared with the adjacent non-cancerous tissue (Fig. 1B) .
Overexpression of miR-29a reduces cell proliferation and inhibits the migration of ESCC cells.
To investigate the biological role of miR-29a in ESCC progression, the ESCC TE-1 cell line was transfected with lentivirus containing the miR-29a precursor or scramble control. The overexpression of miR-29a reduced cell proliferation and resulted in an accumulation of G0/G1 phase cells, indicating that miR-29a induces G0/G1 arrest in TE-1 cells (Fig. 2A, B, C) . Furthermore, the ability of miR-29a to regulate cell proliferation was indicated by a colony formation assay, which demonstrated that miR-29a significantly decreased the colony formation ability of TE-1 cells (Fig. 2D) . Long intervals are required to measure cell migration or to observe healing of scratches in cancer cell monolayers (13) ; after 72 h, overexpression of miR-29a significantly inhibited the ability of TE-1 cells to heal following scratching (Fig. 2E) . To investigate the effect of miR-29a on cell migration over a shorter interval (16 h), thereby minimizing the confounding effect of cell proliferation, TE-1 cell migration was stimulated with EGF (Sigma-Aldrich). The motility of TE-1 cells overexpressing miR-29a was significantly slower compared with that of the control (Fig. 2F) .
Overexpression of miR-29a upregulates Hes1 and downregulates Nfia. RT-qPCR and western blot analysis were used to (Fig. 3A) and protein (Fig. 3B) expression levels of Notch1 did not significantly change in miR-29a-overexpressing-TE-1 cells; however, Hes1, located downstream of the Notch signaling pathway, was significantly upregulated and Nfia, which reduces Hes1 expression by repressing Hes1 promoter transcriptional activity, was downregulated by miR-29a overexpression.
Investigations into the mechanism for the downregulation of Nfia expression by miR-29a resulted in the identification of a potential binding site for miR-29a at position 240-246 of the Nfia 3'UTR mRNA (Fig. 3C) . It was hypothesized that miR-29a represses Nfia expression via this site; thus, reporter vectors, containing luciferase complementary DNA followed by the Nfia 3'UTR, were constructed (Fig. 3D) . TE-1 cells were transfected with the miR-29a precursor or scrambled virus for 4 days, and the resultant miR-29a-overexpressing TE-1 cells were then transfected with the reporter vectors. Luciferase activity was significantly decreased in the miR-29a-overexpressing reporter vector (Fig. 3E ). This demonstrates that miR-29a directly inhibited Nfia expression by binding to its mRNA.
Knockdown of Nfia increases Hes1 expression and inhibits the growth of TE-1 cells.
TE-1 cells were transfected with lentivirus-containing siRNA against Nfia or the scramble RNA control. The knockdown of Nfia significantly increased the gene (Fig 4A) and protein (Fig 4B) expression levels of Hes1 in TE-1 cells. Furthermore, the knockdown of Nfia reduced cell proliferation and resulted in an accumulation of cells in the G0/G1 phase (Fig. 4C) .
Discussion
miRNAs are small, endogenous, non-coding RNA molecules that regulate the expression of protein-coding genes. miRNAs appear to affect numerous biological processes and diseases (14, 15) . Although the mechanisms of various miRNAs remain poorly understood, and the existence of specific miRNAs remains controversial, recent studies have provided significant insights the miR-29 family, including its biology and relevance to cancer (16, 17) . Mature miR-29s in humans include hsa-miR-29a, -29b, and -29c, which are highly conserved in humans, mice and rats (17) . All mature miR-29s share identical sequences at nucleotide positions 2-7, the seed region that is key in determining which protein-coding genes an miRNA targets (17) .
The downregulation of miR-29 family members has been correlated with various types of cancer, including leukemia (18, 19) , melanoma (20) , and liver (21), colon (22) , cervical (23) and lung (24, 25) cancer; thus, miR-29s may serve as tumor suppressors. In the present study, miR-29a was initially demonstrated to be downregulated in ESCC tissue and ESCC TE-1 cells. It has been reported that the dysfunction of miR-29a results in abnormal cell growth (16, 26) . In the current study, in order to investigate the role of miR-29a in ESCC, an assay of the cell cycle of TE-1 cells was conducted following pre-miR-29a transfection-induced miR-29a overexpression. Overexpression of miR-29a markedly arrested the cell cycle in the G0/G1 transition, indicating that miR-29a predominantly regulates ESCC cell proliferation through the modulation of cell cycle progression. In numerous studies, the downregulation of miR-29 has been shown to correlate with the motility and migration of carcinoma cells (27) (28) (29) (30) . In the present study, the overexpression of miR-29a reduced cell migration in TE-1 cells. These results indicate that miR-29a downregulation results in uncontrolled cell cycle progression in ESCC cells and is involved in ESCC tumorigenesis.
The Notch signaling pathway is a highly conserved cell signaling system, present in the majority of multicellular organisms. The Notch signaling pathway is involved in cell fate decisions during normal development and during the development of various types of cancer (7) . The Notch signaling pathway is present in all metazoans and includes four different Notch receptors, termed NOTCH1, NOTCH2, NOTCH3 and NOTCH4. When the Notch signaling pathway is activated, the intracellular domain is released and enters the cell nucleus to modify gene expression, including that of Hes-1. In the present study, it was identified that miR-29a overexpression did not affect Notch1 gene expression levels but did increase the expression levels of its downstream gene, Hes1. Unlike the majority of signaling pathways, Notch signaling can be oncogenic or tumor-suppressive, depending on the cellular context (7) . In ESCC cells, Ohashi et al (31) reported that downregulation of the Notch signaling pathway resulted in the attenuation of squamous cell differentiation and the enhancement of an invasive subset of ESCCs, indicating that Notch may act as tumor suppressor in ESCCs. Thus, the present study proposes that the overexpression of miR-29a reduces cell growth and migration by activating the Notch signaling pathway in TE-1 cells.
Furthermore, the present study investigated the mechanisms by which miR-29a modulates Hes1 gene expression levels and identified that the transcription factor Nfia may be key in this progression. Nfia belongs to the nuclear factor I (NFI) family of site-specific DNA-binding proteins, which are important in various fields, including animal physiology, biochemistry and pathology. NFI proteins have been associated with changes in the growth state of cells and with a number of oncogenic processes and disease states. Previous studies demonstrated that Nfia reduces the expression of Hes1 by repressing transcriptional activity under the control of the Hes1 promoter (32) . In the present study, miR-29a overexpression decreased Nfia gene and protein expression levels in TE-1 cells. In addition to the gene prediction analysis conducted by TargetScan, this observation clarified that Nfia is the direct target gene of miR-29a. In order to verify the role of Nfia in TE-1 cells, Nfia was knocked down; this resulted in increased Hes1 gene and protein expression levels and inhibited the TE-1 cell growth. Thus, the results of the present study demonstrated that the overexpression of miR-29a downregulated Nfia, which in turn increased the Hes1 expression in TE-1 cells. Therefore, the present study proposes that Notch pathway-targeted therapy using miR-29a may be a promising treatment for ESCC.
In conclusion, the present study proposes that miR-29a is an important miRNA that negatively regulates the Notch signaling pathway by targeting Nfia and modulating Hes1 expression. The study demonstrated that miR-29a was poorly expressed in ESCC and involved in ESCC tumorigenesis.
Furthermore, data from the present study indicates that overexpression of miR-29a inhibits the growth of TE-1 cells, supporting the therapeutic potential of this novel miRNA in ESCC.
